describ
new
approach
infecti
diseas
surveil
facilit
rapid
identif
known
emerg
pathogen
process
use
broadrang
polymeras
chain
reaction
pcr
amplifi
nucleic
acid
target
larg
group
organ
electrospray
ioniz
mass
spectrometri
accur
mass
measur
pcr
product
base
composit
signatur
analysi
identifi
organ
sampl
demonstr
principl
use
isol
divers
coronaviru
spp
includ
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
show
method
could
identifi
distinguish
sar
known
cov
includ
human
cov
individu
mixtur
human
virus
sensit
detect
measur
use
titer
sarscov
spike
human
serum
pfuml
approach
applic
surveil
bacteri
viral
fungal
protozo
pathogen
capabl
autom
analysi
pcr
reaction
per
day
n
ucleic
acid
test
infecti
diseas
primarili
base
amplif
method
use
primer
probe
design
detect
specif
organ
prior
knowledg
nucleic
acid
sequenc
inform
requir
develop
test
abl
identifi
unanticip
newli
emerg
previous
unknown
infecti
organ
thu
discoveri
new
infecti
organ
still
reli
larg
cultur
method
microscopi
import
recent
identif
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
discoveri
hiv
decad
ago
broadrang
polymeras
chain
reaction
pcr
method
provid
altern
singleag
test
amplifi
gene
target
conserv
across
group
organ
broadrang
pcr
potenti
gener
amplif
product
across
entir
genera
famili
bacteria
entir
domain
life
strategi
success
use
consensu
ribosom
rna
primer
determin
bacteri
divers
environment
sampl
natur
human
flora
broadrang
prime
also
describ
detect
sever
viral
famili
includ
cov
enterovirus
retroid
virus
adenovirus
drawback
approach
epidemiolog
applic
analysi
pcr
product
mix
amplifi
sampl
requir
sequenc
hundr
coloni
per
reaction
impract
perform
rapidli
larg
number
sampl
new
approach
parallel
detect
multipl
infecti
agent
includ
multiplex
pcr
method
microarray
strategi
microarray
strategi
promis
undiscov
organ
might
detect
hybrid
probe
design
conserv
region
known
famili
bacteria
virus
present
altern
approach
rapid
sensit
highthroughput
detect
infecti
organ
use
broadrang
pcr
gener
amplif
product
broadest
possibl
group
organ
follow
electrospray
ioniz
mass
spectrometri
base
composit
analysi
product
base
composit
strateg
select
region
genom
use
identifi
distinguish
organ
sampl
enhanc
breadth
prime
achiev
use
primer
probe
contain
deoxycytidin
deoxyuridin
nucleotid
offer
increas
affin
base
pair
select
posit
primidinemodifi
nucleotid
highli
conserv
posit
enabl
prime
short
consensu
region
significantli
increas
extent
broad
group
organ
amplifi
tabl
list
cov
use
studi
multipl
sequenc
align
avail
cov
nucleotid
sequenc
genbank
scan
identifi
pair
potenti
pcr
prime
loci
two
target
region
select
cov
annot
base
snijder
et
al
rnadepend
rna
polymeras
rdrp
tabl
propynylmodifi
pyrimidin
nucleotid
shown
bold
posit
univers
conserv
posit
within
primer
extend
breadth
broadrang
prime
allow
effici
pcr
cov
speci
test
primer
region
databas
expect
base
composit
g
c
base
count
known
cov
sequenc
genbank
gener
data
shown
use
identif
classif
test
isol
sever
isol
use
studi
genom
sequenc
record
genbank
experiment
measur
base
composit
isol
independ
verifi
sequenc
bp
region
flank
target
region
use
studi
genbank
access
no
rna
isol
covinfect
cell
cultur
supernat
spike
shear
polya
dna
use
trizol
trizol
ls
respect
invitrogen
inc
carlsbad
ca
usa
accord
manufactur
protocol
revers
transcript
perform
mix
purifi
rna
water
treat
diethyl
pyrocarbon
depc
sigmaaldrich
co
st
loui
mo
usa
contain
ng
random
primer
shear
polya
dna
u
superasein
ambion
inc
woodland
tx
usa
mixtur
heat
min
cool
follow
anneal
random
primer
rna
firststrand
reaction
mix
consist
firststrand
buffer
invitrogen
inc
mmoll
dtt
deoxynucleosid
triphosph
dntp
u
superscript
ii
ad
rna
primer
mixtur
rna
revers
transcrib
min
variou
dilut
revers
transcript
reaction
mix
use
directli
pcr
reaction
pcr
reaction
perform
microtit
plate
mj
dyad
thermocycl
mj
research
waltham
usa
pcr
reaction
buffer
consist
u
amplitaq
gold
appli
biosystem
foster
citi
ca
usa
buffer
ii
appli
biosystem
foster
citi
ca
usa
mmoll
mgcl
moll
betain
dntp
mix
nmoll
propynecontain
pcr
primer
follow
pcr
condit
use
amplifi
cov
sequenc
min
follow
cycl
pcr
amplifi
product
desalt
analysi
electrospray
ioniz
fourier
transform
ion
cyclotron
reson
mass
spectrometri
esifticrm
method
describ
previous
small
oligonucleotid
cgtgcatggcgg
synthet
genet
san
diego
ca
usa
ad
intern
mass
standard
final
concentr
nmoll
mass
spectromet
use
work
base
bruker
dalton
billerica
usa
apex
ii
esifticrm
use
activ
shield
tesla
superconduct
magnet
aspect
puls
sequenc
control
data
acquisit
perform
ghz
pentium
ii
data
station
run
bruker
xmass
softwar
bruker
dalton
input
signal
processor
raw
mass
spectra
parallel
pcr
reaction
use
analyz
singl
sampl
softwar
packag
use
deconvolut
mass
spectra
calcul
mass
monoisotop
speci
use
averagin
fit
routin
modifi
dna
drader
et
al
unpub
data
use
approach
monoisotop
molecular
weight
calcul
spectral
signal
algorithm
process
yield
base
composit
data
describ
previous
amplitud
spectra
calibr
indic
number
molecul
detect
mass
spectromet
versu
mz
mz
valu
correct
use
intern
mass
standard
algorithm
comput
organ
ident
abund
consist
observ
pcr
reaction
run
input
sampl
broadrang
detect
cov
pcr
primer
target
region
shown
tabl
use
viru
list
tabl
result
product
desalt
analyz
fticrm
method
describ
previous
spectral
signal
algorithm
process
yield
base
composit
data
figur
show
schemat
represent
electrospray
ioniz
strand
separ
actual
charg
state
distribut
separ
sens
antisens
strand
pcr
product
rdrp
primer
pair
sarscov
due
accuraci
fticrm
mass
measur
error
ppm
detect
mass
could
unambigu
convert
base
composit
sens
antisens
strand
one
limit
molecular
method
detect
pathogen
includ
one
describ
unexpect
variat
pcr
primer
target
sequenc
unknown
speci
lead
miss
detect
minim
possibl
primer
design
studi
select
basi
highli
conserv
region
identifi
multipl
sequenc
align
previous
known
cov
speci
sequenc
chose
amplif
target
redund
detect
cov
increas
resolut
distinguish
differ
viral
speci
primer
pair
test
multipl
isol
previous
known
cov
speci
group
sarscov
isol
result
analysi
cov
isol
shown
tabl
target
region
measur
signal
agre
composit
expect
known
cov
sequenc
genbank
sever
isol
use
studi
genom
sequenc
record
genbank
nevertheless
abl
amplifi
test
virus
experiment
determin
base
composit
experiment
determin
base
composit
confirm
sequenc
data
shown
thu
strategi
describ
enabl
identif
organ
without
need
prior
knowledg
sequenc
provid
broad
rang
primer
fail
amplifi
target
excess
number
mismatch
demonstr
potenti
detect
multipl
virus
sampl
might
occur
coinfect
pool
viral
extract
human
cov
sarscov
analyz
mixtur
signal
virus
clearli
detect
resolv
mass
spectra
figur
demonstr
coinfect
cov
speci
could
identifi
previous
determin
system
reliabl
detect
multipl
speci
ratio
vari
input
load
organ
data
shown
determin
sensit
clinic
sampl
viabl
titer
sarscov
ad
human
serum
analyz
way
first
rna
isol
serum
contain
concentr
viru
x
pfuml
revers
transcrib
cdna
random
primer
serial
dilut
pcr
amplif
rdrp
primer
set
use
approach
assay
sensit
pfu
per
pcr
reaction
pfuml
serum
estim
number
reversetranscrib
sar
genom
competit
quantit
pcr
nucleic
acid
intern
standard
data
shown
analysi
ratio
mass
spectral
peak
height
titrat
intern
standard
sar
cdna
show
reversetranscrib
viral
genom
present
per
pfu
similar
ratio
viral
genom
copi
per
pfu
previous
report
rna
virus
use
estim
pcr
primer
sensit
genom
equival
per
pcr
reaction
consist
previous
report
detect
limit
optim
sarsspecif
primer
second
method
spike
dilut
sar
viru
serum
rtpcr
could
reliabl
detect
pfu
genom
per
pcr
reaction
pfu
x
genom
per
ml
serum
discrep
detect
sensit
experiment
protocol
describ
suggest
loss
associ
rna
extract
revers
transcript
littl
viru
present
genom
copi
start
sampl
serum
find
consist
result
direct
measur
rna
virus
patient
sampl
therefor
practic
experiment
analysi
tissu
sampl
limit
sensit
pfu
per
pcr
reaction
describ
novel
approach
use
base
composit
analysi
viral
identif
howev
sinc
rna
viru
nucleotid
sequenc
mutat
time
within
function
constraint
allow
select
pressur
util
method
correctli
classifi
rna
virus
depend
resolut
need
particular
applic
consid
specif
applic
first
distinguish
sarscov
speci
cov
infect
human
name
second
applic
util
techniqu
explor
anim
reservoir
discoveri
sarsrel
cov
speci
quantit
analyz
resolv
power
base
composit
mathemat
model
base
composit
variat
use
known
sequenc
multipl
isol
hepat
c
viru
hcv
genbank
h
leven
et
al
unpub
data
hcv
sequencederiv
mutat
probabl
use
estim
extent
base
composit
variat
cov
speci
figur
show
plot
base
composit
rdrp
target
region
cov
known
infect
human
bc
repres
net
chang
composit
requir
strain
variant
misidentifi
sar
probabl
occurr
chang
cumul
probabl
misclassifi
either
sar
use
base
composit
measur
target
region
low
even
allow
unseen
variat
virus
thu
use
human
clinic
diagnost
base
composit
analysi
target
region
describ
would
provid
corrobor
inform
accur
speci
identif
cov
infect
determin
util
base
composit
analysi
search
anim
cov
speci
calcul
cumul
mutat
distanc
target
region
known
cov
plot
group
member
fall
within
certain
probabl
threshold
shown
figur
seri
nest
oval
repres
subgroup
speci
maxim
distanc
known
member
subgroup
repres
next
oval
use
classif
metric
sarscov
would
consid
first
member
new
group
cov
member
core
group
cluster
although
would
place
closest
group
find
similar
recent
describ
snijder
et
al
use
sequenc
data
replicas
gene
bp
suggest
sarscov
close
relat
possibl
earli
splitoff
group
cov
howev
substanti
space
exist
around
sarscov
yet
undiscov
sarscov
could
popul
subgroup
without
confus
group
cov
tabl
plot
g
c
axe
count
shown
tilt
symbol
within
speci
known
isol
viru
isol
sar
ident
sequenc
region
bc
repres
number
chang
g
c
base
need
speci
misidentifi
anoth
direct
arrow
repres
pairwis
mutat
distanc
speci
cumul
probabl
bc
occur
strategi
describ
allow
rapid
identif
new
viral
speci
member
previous
character
viral
famili
without
need
prior
knowledg
sequenc
use
integr
electrospray
ioniz
mass
spectrometri
base
composit
analysi
broadrang
pcr
product
broadrang
pcr
reaction
capabl
produc
product
group
organ
rather
singl
speci
inform
content
pcr
reaction
potenti
high
mani
case
includ
sarscov
detect
describ
articl
prime
across
broadli
conserv
region
provid
adequ
speci
detect
taxonom
resolut
case
addit
subspeci
level
classif
becom
import
broad
primer
follow
speciesspecif
primer
detect
even
singl
nucleotid
chang
snp
altern
larger
region
identifi
speci
analyz
sequenc
despit
advanc
high
throughput
sequenc
howev
impract
frontend
detector
routin
survey
detect
set
mass
spectromet
capabl
analyz
complex
pcr
product
rate
minut
per
sampl
process
perform
autom
microtit
plate
format
larg
number
sampl
examin
pcr
reactionsdayinstru
make
process
practic
largescal
analysi
clinic
environment
surveil
sampl
public
health
laboratori
set
current
gener
esi
mass
spectromet
use
detector
cost
approxim
us
oper
hour
per
day
train
technician
tool
analyz
mass
spectrometri
data
wide
avail
describ
detail
elsewher
compar
altern
method
describ
microarray
also
provid
broad
rang
detect
approach
extend
viral
bacteri
fungal
protozo
pathogen
group
power
new
paradigm
time
identif
previous
unknown
organ
caus
diseas
human
anim
monitor
progress
epidem
studi
use
platform
technolog
fund
part
depart
defens
darpa
special
project
offic
develop
tiger
technolog
contract
patent
current
pend
unit
state
intern
addit
fund
support
provid
grant
nation
institut
health
ai
mb
ns
bn
author
except
mb
bn
employe
stockhold
isi
pharmaceut
inc
dr
sampath
director
genom
comput
biolog
ibi
therapeut
divis
isi
pharmaceut
inc
lead
ibi
genom
effort
microbi
detect
diagnosi
research
interest
includ
pathogen
discoveri
epidemiolog
surveil
clinic
infecti
diagnost
emerg
infecti
diseas
wwwcdcgoveid
vol
represent
mutat
distanc
calcul
select
primer
set
overlaid
coronaviru
phylogenet
tree
oval
repres
group
member
contain
within
number
next
group
indic
maximum
distanc
member
group
distanc
comput
base
logarithm
geometr
averag
pairwis
probabl
given
pair
base
composit
